In 2014, only 32 percent of Medicaid-enrolled children received any oral health care, according to Florida data submitted to the federal government. Without proper dental care from the time children sprout their first tooth, they can be set up for a lifetime of tooth decay and cavities.
A local community foundation has teamed up with one of the nation's leading public health researchers to survey more than 5,000 pediatricians throughout the state on their interactions with the Florida Medicaid program.
What's driving some residents in Palm Springs and the Coachella Valley to seek out health care in Mexico? It turns out it's not just a question of money or cultural familiarity, as Barrett Newkirk reports.
Next week, the Center for Health Journalism will host 21 reporters for our 2016 California Fellowship. Fellows and their newsrooms partner with our Center to produce ambitious projects on health topics. Here's a look at the talented crew that will be joining us.
Nearly 4 million Californians lack health insurance coverage, and nearly three out of five uninsured residents are Latino or Hispanic. Is the state and its health exchange, Covered California, doing enough to get Latinos insured?
Obamacare enabled a wave of residents in California’s Central San Joaquin Valley to get health insurance, but finding doctors has been a recurring challenge for many. Is there any relief on the horizon?
On health care, the talk from presidential candidates has been way too sketchy and uninformative, argues contributing editor Trudy Lieberman. Policy details remain vague, and no one has gotten to the heart of what ails the system.
Rural hospitals have been closing at alarming rate across the nation, including California's Central Valley. What happens to rural residents when a local hospital closes it doors? And is telemedicine really the solution?
A new Health Matters webinar this week explored just how different the health care spending map looks when researchers are given access to price and spending data from private insurance plans.
The specialty drug Orkambi, for cystic fibrosis, has a sticker price of $259,000 per year. What's driving these astronomical costs for specialty drugs? And can California's budget cope?
